Religare review finds five control gaps, no new financial impact

Religare Enterprises Limited said a governance review covering April 1, 2018 to February 28, 2025 identified five areas for stronger controls, while Trilegal’s November 9, 2026 final report found no adverse financial impact beyond amounts already provided for in financial statements. The Board considered the report on November 12, 2026.

What did Religare’s governance review find?

Religare’s review found gaps in conflict identification, business-rationale assessment, vendor selection, payment monitoring, and expense and asset governance during the April 1, 2018 to February 28, 2025 review period. The work covered legacy general-business-conduct matters at Religare and its subsidiaries, Religare Finvest Limited and Religare Housing Development Finance Corporation Limited, under the erstwhile management.

Religare said the review was commissioned to strengthen monitoring and control activities, and to improve compliance, decision-making and operational transparency. The company had informed stock exchanges on March 17, 2025 that it was commissioning the review, while the Board received Trilegal’s final report dated November 9, 2026 at its November 12, 2026 meeting.

Religare did not disclose individual transactions, vendors, executives, instance counts or amounts connected with the five observations. It said the areas relate to processes for initiating, assessing, executing and approving transactions and expenditure, and that it proposes to address them in a phased manner after the November 2026 report.

How did the review address conflicts and connected relationships?

Religare said some relationships or associations involving senior management, external counterparties and connected individuals were not captured through a formal conflict assessment or independent-review process during the review period ending February 28, 2025. The filing does not specify the number of instances or a financial value for the relationships identified.

Religare’s proposed response is a conflict register, relationship declarations, an enhanced approval matrix and recusal documentation. These measures were listed in the November 12, 2026 disclosure as the control-improvement focus for identifying relevant relationships and recording cases in which an involved person does not participate in an approval.

The conflict observation is separate from the vendor-selection finding in the same report. The conflict theme refers to senior management, counterparties and connected individuals, whereas the vendor theme specifically identifies connected-vendor screening, alongside benchmarking, capability assessment and comparative evaluation of appointments.

What were the vendor and payment-control shortcomings?

Religare said certain vendor appointments and retainerships were not adequately supported by independent comparative evaluation, benchmarking, capability assessment or connected-vendor screening. The November 9, 2026 report did not state the number, value, date or identity of vendor appointments covered by that observation.

Religare plans to introduce documentation of economic rationale, comparative evaluation and vendor due diligence for vendor selection. The disclosed control focus addresses the appointment stage, before a service provider is engaged, and applies to the vendor and retainership processes reviewed for April 2018 to February 2025.

Religare also said certain payments were made without clear linkage to milestones, deliverables, progress reports or acceptance documentation. Its proposed response is comprehensive policies and processes for procuring services across the full lifecycle, connecting provider selection, service delivery evidence and payment approval.

The two findings concern different transaction stages in the November 2026 disclosure. Vendor evaluation concerns the basis for selecting a provider, while monitoring deliverables and payments concerns whether records support payment after services or other deliverables are due.

Which expenses lacked documented business justification?

Religare said certain sponsorships, events, travel items, retainerships and property arrangements did not have adequate documentation of business objectives, expected outcomes or, where warranted, post-facto benefit assessment. The report names five activity categories but does not describe any expenditure as improper or attach an amount to any category.

Religare’s planned measures are business-case notes, expected-outcome metrics and post-event or output assessment where warranted. The stated focus is to document the intended commercial purpose and anticipated result for the activities reviewed from April 1, 2018 to February 28, 2025.

Separately, the expense and asset-governance finding said certain event, travel, property and asset-related spending was recorded as business expenditure without adequate contemporaneous verification or justification of business purpose. The final report also identified expenditure approval processes that permitted self-approval for senior management.

Religare listed expense certification, supporting evidence, periodic audit and exception reporting as the response to the expense and asset-governance issue. This differs from the business-rationale finding because it concerns verification, evidence and approval of recorded expenditure, rather than only the objectives and expected benefits of an activity.

Did the review identify a new financial impact?

No. Religare said Trilegal’s final report found no implications or adverse financial impact on its past, current or future financial and operational position, other than amounts already provided for in its financial statements. The November 12, 2026 filing did not quantify the provisions already recorded.

The governance update accompanied Religare’s unaudited standalone and consolidated results for the quarter and half year ended September 30, 2026. On a standalone basis, Religare reported a net loss of Rs 13.4368 crore for the September 2026 quarter, compared with a net loss of Rs 3.9738 crore in the September 2025 quarter; the filing does not link that year-on-year change to the review.

For the half year ended September 30, 2026, Religare’s standalone net loss was Rs 23.0565 crore, compared with Rs 10.1219 crore in the corresponding half year ended September 30, 2025. The company’s review conclusion does not identify a new earnings adjustment, stating instead that any relevant financial effect had already been provided for in the financial statements.

Conclusion

Religare’s November 2026 disclosure identifies control gaps across the path from declaring conflicts and selecting vendors to documenting business purpose, verifying delivery and approving expenses. The report did not disclose transaction values or individuals, and Religare said its financial impact assessment found no additional adverse effect beyond existing provisions.

The next disclosed item to watch is Religare’s phased implementation of the conflict register, relationship declarations, approval changes, vendor due diligence, full-lifecycle procurement processes, expense certification, periodic audits and exception reporting. The Board said it would promptly inform stock exchanges of significant developments or findings arising from the review.